Laurion Capital Management »

ImmunoGen shares owned by Laurion Capital Management

Quarter-by-quarter ownership of ImmunoGen shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.9M 65k 29.65
2018-03-31 $144k 14k 10.51

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Meta Platforms Cl A Call Option (META)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Apple (AAPL)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Broadcom Call Option (AVGO)
Ishares Tr Msci Eafe Etf (EFA)
Tesla Motors Call Option (TSLA)
Boeing Company (BA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Home Depot (HD)
JPMorgan Chase & Co. Call Option (JPM)
Adobe Systems Incorporated (ADBE)

View all positions for Laurion Capital Management

Top funds holding ImmunoGen

Wellington Management Company
Healthcare Of Ontario Pension Plan Trust Fund
Alliancebernstein
venBio Select Advisor
Decheng Capital
Hsbc Holdings
PRIMECAP Management Company
Allianz Asset Management
DLD Asset Management
Nicholas Investments Partners
MetLife Investment Advisors
American International
Guggenheim Capital, LLC Managers
Angelo, Gordon & Co
Kellner Capital

View all funds holding ImmunoGen